Hamid Riazi-Esfahani Selected Research

Hamid Riazi-Esfahani Research Topics

Disease

6	Retinopathy of Prematurity (Retrolental Fibroplasia) 07/2022 - 01/2018
6	Macular Edema 07/2021 - 04/2018
5	Retinal Detachment (Retinal Detachments) 04/2022 - 01/2020
5	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2022 - 07/2019
3	Macular Degeneration (Age-Related Maculopathy) 11/2021 - 10/2014
3	Retinal Vein Occlusion 02/2021 - 07/2019
3	Cataract (Cataracts) 01/2021 - 04/2018
2	COVID-19 11/2022 - 05/2021
2	Endophthalmitis (Ophthalmia) 11/2022 - 01/2021
2	Lymphoma (Lymphomas) 04/2022 - 02/2022
2	Melanoma (Melanoma, Malignant) 11/2021 - 01/2020
2	Choroidal Neovascularization 01/2021 - 01/2020
2	Retinoblastoma (Glioblastoma, Retinal) 01/2021 - 01/2021
2	Neoplasms (Cancer) 01/2021 - 01/2021
1	Proliferative Vitreoretinopathy 02/2022
1	Necrosis 01/2022
1	Retinitis 01/2022
1	Ischemia 10/2021
1	Vision Disorders (Hemeralopia) 09/2021
1	Infections 05/2021
1	Retinal Dystrophies 05/2021
1	Vascular Diseases (Vascular Disease) 02/2021
1	Optic Atrophy 01/2021
1	Glaucoma 01/2021
1	Hyphema 01/2021
1	Disease Progression 01/2021
1	Vitreous Hemorrhage 01/2021
1	Corneal Injuries 01/2021
1	Central Serous Chorioretinopathy 01/2021
1	Ocular Toxoplasmosis 01/2021
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2021
1	Toxic Optic Neuropathy 01/2021
1	Pharyngitis (Sore Throat) 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Sickle Cell Trait 01/2021
1	Atrophy 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2020
1	Paresis (Hemiparesis) 04/2020
1	Cysts 03/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Diabetes Mellitus 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Ischemic Stroke 01/2020
1	Choroiditis 06/2019
1	Sclerosis 06/2018

Drug/Important Bio-Agent (IBA)

18	Retinaldehyde (Retinal)IBA 04/2022 - 10/2014
7	Bevacizumab (Avastin)FDA Link 07/2022 - 01/2018
4	Silicone OilsIBA 02/2022 - 12/2020
3	afliberceptIBA 10/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2022 - 01/2020
1	Rituximab (Mabthera)FDA Link 04/2022
1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2022
1	Ruthenium-106IBA 11/2021
1	RutheniumIBA 11/2021
1	Carbonic Anhydrase InhibitorsIBA 05/2021
1	dorzolamide (Trusopt)FDA LinkGeneric 05/2021
1	Retinal Pigments (Pigments, Visual)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Digoxin (Digitek)FDA LinkGeneric 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	closantelIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	TabletsIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 07/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 07/2020
1	Fish OilsIBA 01/2020
1	LipidsIBA 01/2020
1	EmulsionsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	salicylhydroxamic acid (SHAM)IBA 07/2019
1	Ranibizumab (Lucentis)FDA Link 07/2019
1	Tuberculin (PPD)IBA 06/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 06/2018
1	Capsules (Microcapsules)IBA 06/2018
1	Triamcinolone (Aristocort)FDA Link 04/2018
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 04/2018

Therapy/Procedure

6	Vitrectomy 02/2022 - 07/2015
5	Light Coagulation 02/2022 - 01/2018
4	Injections 11/2022 - 01/2021
3	Intravitreal Injections 11/2022 - 07/2019
3	Drug Therapy (Chemotherapy) 04/2022 - 01/2021
2	Radiotherapy 04/2022 - 11/2021
2	Aftercare (After-Treatment) 11/2021 - 04/2018
2	Brachytherapy 11/2021 - 01/2020
2	Scleral Buckling 09/2020 - 01/2020
1	Immunotherapy 04/2022
1	Orthoptics (Orthoptic) 09/2021
1	Immunomodulation 05/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2021
1	Craniotomy 04/2020
1	Therapeutics 06/2019
1	Intraocular Lenses (Intraocular Lens) 06/2018
1	Phacoemulsification 06/2018